Secretion of neublastin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7601518
APP PUB NO 20050089960A1
SERIAL NO

10864891

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns improved methods and compositions for producing a Neublastin polypeptide as well as local delivery of Neublastin to specific regions of the nervous system including the central nervous system and the eye for example by gene therapy. The invention also concerns Neublastin expression constructs which do not encode a pro-region of a Neublastin polypeptide, which expression construct result in increased secretion of bioactive Neublastin. The invention includes the delivery of Neublastin from transduced or transfected cells encapsulated into a macrocapsule with a semipermeable membrane. The invention further concerns mammalian cells capable of producing Neublastin in increased amounts.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NSGENE A/S

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gronborg, Mette Copenhagen Nv , DK 10 50
Kusk, Philip Lynge , DK 11 65
Tornoe, Jens Copenhagen O , DK 7 48
Wahlberg, Lars U Asnaes , DK 11 54

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation